1. Home
  2. PDLB vs EOLS Comparison

PDLB vs EOLS Comparison

Compare PDLB & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$15.71

Market Cap

377.3M

Sector

N/A

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.87

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
EOLS
Founded
1960
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
377.3M
444.0M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
PDLB
EOLS
Price
$15.71
$6.87
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.80
AVG Volume (30 Days)
72.7K
1.4M
Earning Date
01-27-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
142.83
N/A
EPS
0.89
N/A
Revenue
$96,252,000.00
$285,823,000.00
Revenue This Year
$10.97
$14.36
Revenue Next Year
$8.59
$23.27
P/E Ratio
$17.65
N/A
Revenue Growth
26.04
15.10
52 Week Low
$10.88
$5.71
52 Week High
$16.09
$17.12

Technical Indicators

Market Signals
Indicator
PDLB
EOLS
Relative Strength Index (RSI) 55.84 50.64
Support Level $15.29 $6.36
Resistance Level $16.09 $7.15
Average True Range (ATR) 0.42 0.29
MACD 0.01 -0.03
Stochastic Oscillator 71.65 55.74

Price Performance

Historical Comparison
PDLB
EOLS

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: